Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
D000818:Animals; D002402:Cathepsin D; D002403:Cathepsins / Q000037:antagonists & inhibitors*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005450:Fluorescamine; D007705:Kinins / Q000302:isolation & purification; D051379:Mice; D008811:Mice, Inbred DBA; D009374:Neoplasms, Experimental / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology*; D010436:Pepstatins / Q000494:pharmacology*; D014405:Tuftsin / Q000096:biosynthesis* / Q000302:isolation & purification; D005719:gamma-Globulins / Q000096:biosynthesis*
D007705:Kinins; D009842:Oligopeptides; D010436:Pepstatins; D005719:gamma-Globulins; D005450:Fluorescamine; D002403:Cathepsins; D002402:Cathepsin D; D014405:Tuftsin